Dirk Jäger - Concepedia

Author

Dirk Jäger

National Center for Tumor Diseases

Also Known As

D Jäger, D. Jager, D. Jäger, D. Jäger, D. Jäger, DIRK JÄGER, Dirk Jager, Dirk Jäger, Dirk Jäger, Dirk Jāger

211

Publications

9.4K

Citations

H-Index

Concepts

All Affiliations

National Center for Tumor Diseases Heidelberg University University Hospital Heidelberg German Cancer Research Center Krankenhaus Nordwest

About

Dirk Jäger is an author at National Center for Tumor Diseases specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	40	3.8K
2	Engineering	5	5	2K
3	Health Sciences	2	2	37
4	Natural Sciences	1	1	79
5	Biomedical Engineering	1	1	171

Dirk Jäger

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164 Dung T. Le, Tae Won Kim, Eric Van Cutsem, Journal of Clinical Oncology	2019	975
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein Thomas Lindner, Anastasia Loktev, Annette Altmann, Journal of Nuclear Medicine EngineeringTumor BiologyTheranosticsFibroblast Growth FactorAnti-cancer Agent	2018	874
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts Anastasia Loktev, Thomas Lindner, Walter Mier, Journal of Nuclear Medicine EngineeringOncologic ImagingPathologyCancer-associated FibroblastsTumor Biology	2018	729
<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Journal of Nuclear Medicine	2018	674
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Journal of Nuclear Medicine	2019	499
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Proceedings of the National Academy of Sciences	2000	426
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic, Proceedings of the National Academy of Sciences	2000	398
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors Sylvie Rusakiewicz, Michaëla Semeraro, Matthieu Sarabi, Cancer Research T-regulatory CellImmunologyGastroenterologyPathologyNk Cells	2013	295
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer Ali O. Güre, Elisabeth Stockert, Matthew J. Scanlan, Proceedings of the National Academy of Sciences	2000	235
Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events Elke Jäger, Elisabeth Stockert, Zacharias Zidianakis, International Journal of Cancer	1999	225

Page 1